Managing Pregnancy in Women with Connective Tissue Disorders: A Comprehensive Clinical Approach

Abstract

Pregnancy in women with connective tissue disorders (CTDs) presents unique clinical challenges, including increased risks for maternal and fetal complications[1]. CTDs such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and undifferentiated connective tissue disease (UCTD) are associated with adverse pregnancy outcomes such as
preterm labor, preeclampsia, and fetal growth restriction[2]. This article presents a clinical
pathway for managing pregnancy in women with CTDs, incorporating early risk identification, pharmacological interventions, and multidisciplinary care strategies to optimize outcomes[3]